PortalPublikationenAdherence to pelvic lymph node dissection recommendations ac...

Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification

Standard

Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification. / Leyh-Bannurah, Sami-Ramzi; Budäus, Lars; Zaffuto, Emanuele; Pompe, Raisa S; Bandini, Marco; Briganti, Alberto; Montorsi, Francesco; Schiffmann, Jonas; Shariat, Shahrokh F; Fisch, Margit; Chun, Felix; Huland, Hartwig; Graefen, Markus; Karakiewicz, Pierre I.

in: UROL ONCOL-SEMIN ORI, Jahrgang 36, Nr. 2, 02.2018, S. 81.e17-81.e24.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Leyh-Bannurah, S-R, Budäus, L, Zaffuto, E, Pompe, RS, Bandini, M, Briganti, A, Montorsi, F, Schiffmann, J, Shariat, SF, Fisch, M, Chun, F, Huland, H, Graefen, M & Karakiewicz, PI 2018, 'Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification', UROL ONCOL-SEMIN ORI, Jg. 36, Nr. 2, S. 81.e17-81.e24. https://doi.org/10.1016/j.urolonc.2017.10.022

APA

Leyh-Bannurah, S-R., Budäus, L., Zaffuto, E., Pompe, R. S., Bandini, M., Briganti, A., Montorsi, F., Schiffmann, J., Shariat, S. F., Fisch, M., Chun, F., Huland, H., Graefen, M., & Karakiewicz, P. I. (2018). Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification. UROL ONCOL-SEMIN ORI, 36(2), 81.e17-81.e24. https://doi.org/10.1016/j.urolonc.2017.10.022

Vancouver

Leyh-Bannurah S-R, Budäus L, Zaffuto E, Pompe RS, Bandini M, Briganti A et al. Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification. UROL ONCOL-SEMIN ORI. 2018 Feb;36(2):81.e17-81.e24. https://doi.org/10.1016/j.urolonc.2017.10.022

Bibtex

@article{553518b85f6b4c629e1c05da01994509,
title = "Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification",
abstract = "PURPOSE: To assess adherence rates to pelvic lymph node dissection (PLND) according to National Comprehensive Cancer Network (NCCN) PLND guideline (2% or higher risk) and D'Amico lymph node invasion (LNI) risk stratification (intermediate/high risk) in contemporary North American patients with prostate cancer treated with radical prostatectomy (RP).MATERIAL AND METHODS: We relied on 49,358 patients treated with RP and PLND (2010-2013) in SEER database. Adherence rates were quantified and multivariable (MVA) logistic regression analyses tested for independent predictors.RESULTS: According to NCCN PLND guideline and D'Amico LNI classification, PLND was recommended in 63.3% and 64.9% of patients, respectively. Corresponding adherence rates were 68.8% and 69.1%. Adherence rates improved from 67.3% to 71.6% and from 67.6% to 72.0%, respectively, over time. In MVA, more advanced clinical stage, higher biopsy Gleason score and higher number of positive biopsy cores predicted PLNDs that were performed below NCCN LNI nomogram risk threshold. Conversely, lower clinical stage, lower PSA and lower biopsy Gleason score predicted PLND omission in individuals with risk level above NCCN LNI nomogram risk threshold. MVA results for D'Amico classification were virtually identical.CONCLUSIONS: Adherence to NCCN PLND guideline and D'Amico LNI classification for purpose of PLND is suboptimal in SEER population-based patients treated with RP. However, adherence rates have improved over time. Patients, who did not undergo PLND despite elevated LNI risk, had more favorable PCa characteristics than the average. Conversely, patients, who underwent PLND despite low-risk, had worse PCa characteristics than the average.",
keywords = "Journal Article",
author = "Sami-Ramzi Leyh-Bannurah and Lars Bud{\"a}us and Emanuele Zaffuto and Pompe, {Raisa S} and Marco Bandini and Alberto Briganti and Francesco Montorsi and Jonas Schiffmann and Shariat, {Shahrokh F} and Margit Fisch and Felix Chun and Hartwig Huland and Markus Graefen and Karakiewicz, {Pierre I}",
note = "Copyright {\textcopyright} 2018 Elsevier Inc. All rights reserved.",
year = "2018",
month = feb,
doi = "10.1016/j.urolonc.2017.10.022",
language = "English",
volume = "36",
pages = "81.e17--81.e24",
journal = "UROL ONCOL-SEMIN ORI",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "2",

}

RIS

TY - JOUR

T1 - Adherence to pelvic lymph node dissection recommendations according to the National Comprehensive Cancer Network pelvic lymph node dissection guideline and the D'Amico lymph node invasion risk stratification

AU - Leyh-Bannurah, Sami-Ramzi

AU - Budäus, Lars

AU - Zaffuto, Emanuele

AU - Pompe, Raisa S

AU - Bandini, Marco

AU - Briganti, Alberto

AU - Montorsi, Francesco

AU - Schiffmann, Jonas

AU - Shariat, Shahrokh F

AU - Fisch, Margit

AU - Chun, Felix

AU - Huland, Hartwig

AU - Graefen, Markus

AU - Karakiewicz, Pierre I

N1 - Copyright © 2018 Elsevier Inc. All rights reserved.

PY - 2018/2

Y1 - 2018/2

N2 - PURPOSE: To assess adherence rates to pelvic lymph node dissection (PLND) according to National Comprehensive Cancer Network (NCCN) PLND guideline (2% or higher risk) and D'Amico lymph node invasion (LNI) risk stratification (intermediate/high risk) in contemporary North American patients with prostate cancer treated with radical prostatectomy (RP).MATERIAL AND METHODS: We relied on 49,358 patients treated with RP and PLND (2010-2013) in SEER database. Adherence rates were quantified and multivariable (MVA) logistic regression analyses tested for independent predictors.RESULTS: According to NCCN PLND guideline and D'Amico LNI classification, PLND was recommended in 63.3% and 64.9% of patients, respectively. Corresponding adherence rates were 68.8% and 69.1%. Adherence rates improved from 67.3% to 71.6% and from 67.6% to 72.0%, respectively, over time. In MVA, more advanced clinical stage, higher biopsy Gleason score and higher number of positive biopsy cores predicted PLNDs that were performed below NCCN LNI nomogram risk threshold. Conversely, lower clinical stage, lower PSA and lower biopsy Gleason score predicted PLND omission in individuals with risk level above NCCN LNI nomogram risk threshold. MVA results for D'Amico classification were virtually identical.CONCLUSIONS: Adherence to NCCN PLND guideline and D'Amico LNI classification for purpose of PLND is suboptimal in SEER population-based patients treated with RP. However, adherence rates have improved over time. Patients, who did not undergo PLND despite elevated LNI risk, had more favorable PCa characteristics than the average. Conversely, patients, who underwent PLND despite low-risk, had worse PCa characteristics than the average.

AB - PURPOSE: To assess adherence rates to pelvic lymph node dissection (PLND) according to National Comprehensive Cancer Network (NCCN) PLND guideline (2% or higher risk) and D'Amico lymph node invasion (LNI) risk stratification (intermediate/high risk) in contemporary North American patients with prostate cancer treated with radical prostatectomy (RP).MATERIAL AND METHODS: We relied on 49,358 patients treated with RP and PLND (2010-2013) in SEER database. Adherence rates were quantified and multivariable (MVA) logistic regression analyses tested for independent predictors.RESULTS: According to NCCN PLND guideline and D'Amico LNI classification, PLND was recommended in 63.3% and 64.9% of patients, respectively. Corresponding adherence rates were 68.8% and 69.1%. Adherence rates improved from 67.3% to 71.6% and from 67.6% to 72.0%, respectively, over time. In MVA, more advanced clinical stage, higher biopsy Gleason score and higher number of positive biopsy cores predicted PLNDs that were performed below NCCN LNI nomogram risk threshold. Conversely, lower clinical stage, lower PSA and lower biopsy Gleason score predicted PLND omission in individuals with risk level above NCCN LNI nomogram risk threshold. MVA results for D'Amico classification were virtually identical.CONCLUSIONS: Adherence to NCCN PLND guideline and D'Amico LNI classification for purpose of PLND is suboptimal in SEER population-based patients treated with RP. However, adherence rates have improved over time. Patients, who did not undergo PLND despite elevated LNI risk, had more favorable PCa characteristics than the average. Conversely, patients, who underwent PLND despite low-risk, had worse PCa characteristics than the average.

KW - Journal Article

U2 - 10.1016/j.urolonc.2017.10.022

DO - 10.1016/j.urolonc.2017.10.022

M3 - SCORING: Journal article

C2 - 29248430

VL - 36

SP - 81.e17-81.e24

JO - UROL ONCOL-SEMIN ORI

JF - UROL ONCOL-SEMIN ORI

SN - 1078-1439

IS - 2

ER -